Advertisement

Phospholipid Metabolism in Nervous Tissues: Modification of Precursor Incorporation and Enzyme Activities by Cationic Amphiphilic Drugs

  • George Hauser
  • Omanand Koul
  • Ubaldo Leli
Part of the FIDIA Research Series book series (FIDIA, volume 4)

Abstract

Although the effects of individual drugs on the incorporation of precursors into lipids in vitro have been sporadically examined for thirty years or so, it is primarily during the last ten years that a substantial body of information has been accumulated in this field. During this time, it has come to be recognized that numerous drugs with varied therapeutic actions share the capacity to redirect phospholipid metabolism. The compounds involved exhibit certain common physical-chemical features of their structures, namely a bulky lipophilic ring system and an aliphatic side-chain containing a quaternary, positively charged nitrogen which bestows hydrophilic character upon the molecule. The typical shift in incorporation of 32Pi into phospholipids, elicited by drugs of this type, manifests itself in enhanced labeling of acidic and reduced labeling of neutral phospholipids. This has been demonstrated in numerous biological systems (Hauser and Pappu, 1982; Abdel-Latif, 1983; Bazan et al., 1985).

Keywords

Cytosolic Enzyme Phospholipid Metabolism Ethanolamine Phosphoglycerides Individual Phospholipid Class Phosphatidate Phosphohydrolase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdel-Latif AA (1983) Metabolism of phosphoinositides. In: Lajtha A (ed): Handbook of Neurochemistry, Vol. 3. Plenum Publishing Corp, New York, pp. 91–131.Google Scholar
  2. Abdel-Latif AA, Smith JP (1976) Effects of DL-propranolol on the synthesis of glycerolipids by rabbit iris muscle. Biochem Pharmacol 25: 1697–1704.PubMedCrossRefGoogle Scholar
  3. Ashcroft RG, Coster HGL, Smith JR (1977) The molecular organization of bimolecular lipid membranes. Biochim Biophys Acta 469: 13–22.PubMedCrossRefGoogle Scholar
  4. Bazan NG, Roccamo de Fernandez AM, Giusto NM, Ilincheta de Boschero MG (1985) Propranolol-induced membrane perturbation and the metabolism of phosphoinositides and arachidonoyl diacylglycerols in the retina. In: Bleasdale J, Eichberg J, Hauser G (eds): Inositol and Phosphoinositides: Metabolism and Regulation. Humana, Clifton, NJ, pp. 67–82.CrossRefGoogle Scholar
  5. Blohm TR (1979) Drug-induced lysosomal lipidosis: biochemical interpretations. Pharmacol Rev 30: 593–603.Google Scholar
  6. Bowley M, Cooling J, Burditt SL, Brindley DN (1977) The effects of amphiphilic cationic drugs and inorganic cations on the activity of phosphatidate phosphohydrolase. Biochem J 165: 447–454.PubMedGoogle Scholar
  7. Brindley DN, Bowley M (1975) Drugs affecting the synthesis of glycerides and phospholipids in rat liver. Biochem J 148: 461–469.PubMedGoogle Scholar
  8. Brumley G, van den Bosch H (1977) Lysophospholipase-transacylase from rat lung, isolation and partial purification. J Lipid Res 18: 523–532.PubMedGoogle Scholar
  9. Casals C, Acebal C, Cruz-Alvarez M, Estrada P, Arche R (1982) Lysolecithin: lysolecithin acyltransferase from rabbit lung: Enzymatic properties and kinetic study. Arch Biochem Biophys 217: 422–433.PubMedCrossRefGoogle Scholar
  10. Cascales C, Mangiapane EH, Brindley DN (1984) Oleic acid promotes the activation and translocation of phosphatidate phosphohydrolase from the cytosol to paniculate fractions of isolated rat hepatocytes. Biochem J 219: 911–916.PubMedGoogle Scholar
  11. Choy PC, Farren SB, Vance DE (1979) Lipid requirements for the aggregation of CTP: phosphocholine cytidylyltransferase in rat liver cytosol. Can J Biochem 57: 605–612.PubMedCrossRefGoogle Scholar
  12. Choy PC, Lim PH, Vance DE (1977) Purification and characterization of CTP: cholinephosphate cytidylyltranferase from rat liver cytosol. J Biol Chem 252: 7673–7677.PubMedGoogle Scholar
  13. Choy PC, Vance DE (1978) Lipid requirements for activation of CTP: phosphocholine cytidylyltransferase from rat liver. J Biol Chem 253: 5163–5167.PubMedGoogle Scholar
  14. Conrad MJ, Singer SJ (1981) The solubility of amphipathic molecules in biological membranes and lipid bilayers and its implications for membrane structure. Biochemistry 20: 808–818.PubMedCrossRefGoogle Scholar
  15. Dawson RMC (1956) The phospholipase B of liver. Biochem J 64: 192–196.PubMedGoogle Scholar
  16. De Jong JGN, van den Bosch H, Aarsman AJ, van Deenen LLM (1973) Studies on lysophospholipases. II. Substrate specificity of a lysolecithin hydrolyzing carboxylesterase from beef pancreas. Biochim Biophys Acta 296: 105–115.PubMedCrossRefGoogle Scholar
  17. Drenckhahn D, Lüllmann-Rauch R (1979) Drug-induced experimental lipidosis in the nervous system. Neuroscience 4: 697–712.PubMedCrossRefGoogle Scholar
  18. Eichberg J, Gates J, Hauser G (1979) The mechanism of modification by propranolol of the metabolism of phosphatidyl-CMP (CDP-diacylglycerol) and other lipids in the rat pineal gland. Biochim Biophys Acta 573: 90–106.PubMedCrossRefGoogle Scholar
  19. Eichberg J, Shein H, Schwartz M, Hauser G (1973) Stimulation of 32Pj incorporation into phosphatidylinositol and phosphatidylglycerol by catecholamines and beta-adrenergic receptor blocking agents in rat pineal organ cultures. J Biol Chem 248: 3615–3622.PubMedGoogle Scholar
  20. Erbland J, Marinetti GV (1962) In vitro metabolism of lysolecithin. Federation Proc 21: 295.Google Scholar
  21. Fiscus WG, Schneider WC (1966) The role of phospholipids in stimulating phosphorylcholine cytidyltransferase activity. J Biol Chem 241: 3324–3330.PubMedGoogle Scholar
  22. Giusto NM, Ilincheta de Boschero MG, Bazan NG (1983) Accumulation of phosphatidic acid from propranolol-treated retinas during short-term incubations. J Neurochem 40: 563–568.PubMedCrossRefGoogle Scholar
  23. Gross RW, Sobel BE (1982) Lysophosphatidylcholine metabolism in the rabbit heart. J Biol Chem 257: 6702–6708.PubMedGoogle Scholar
  24. Hall M, Taylor SJ, Saggerson ED (1985) Persistent activity modification of phosphatidate phosphohydrolase and fatty acyl-CoA synthetase on incubation of adipocytes with the tumour promoter 12-O-tetradecanoylphorbol 13-acetate. FEBS Lett 179: 351–353.PubMedCrossRefGoogle Scholar
  25. Hauser G, Eichberg J (1975) Identification of cytidine diphosphatediglyceride in the pineal gland of the rat and its accumulation in the presence of DL-propranol. J Biol Chem 250: 105–112.PubMedGoogle Scholar
  26. Hauser G, Pappu AS (1982) Effects of propranolol and other cationic amphiphilic drugs on phospholipid metabolism In: Horrocks LA, Ansell GB, Porcellati G (eds): Phospholipids in the Nervous System, Vol. 1. Metabolism. Raven Press, New York, pp. 283–300.Google Scholar
  27. Hokin-Neaverson M (1980) Actions of chloropromazine, haloperidol and pimozide on lipid metabolism in guinea pig brain slices. Biochem Pharmacol 29: 2697–2700.PubMedCrossRefGoogle Scholar
  28. Hostetler KY, Matsuzawa Y (1981) Studies on the mechanism of drug-induced lipidosis. Biochem Pharmacol 30: 1121–1126.PubMedCrossRefGoogle Scholar
  29. Hostetler KY, Zenner BD, Morris HP (1976) Increased mitochondrial CTP: phosphatidic acid cytidyltransferase in the 777 hepatoma. Biochem Biophys Res Commun 72: 418–425.PubMedCrossRefGoogle Scholar
  30. Ide H, Nakazawa Y (1985) Phosphatidate phosphatase in rat liver: The relationship between the activities with membrane-bound phosphatidate and aqueous dispersion of phosphatidate. J Biochem (Tokyo) 97: 45–54.Google Scholar
  31. Jarvis AA, Cain C, Dennis EA (1984) Purification and characterization of a lysophospholipase from human amnionic membranes. J Biol Chem 259: 15188–15195.PubMedGoogle Scholar
  32. Kai M, Salway JG, Hawthorne JN (1968) The diphosphoinositide kinase of rat brain. Biochem J 106: 791–801.PubMedGoogle Scholar
  33. Kanoh H, Kondoh H, Ono T (1983) Diacylglycerol kinase from pig brain. J Biol Chem 258: 1767–1774.PubMedGoogle Scholar
  34. Kunze H, Nahas N, Traynor JR, Wurl M (1976) Effects of local anaesthetics on phospholipases. Biochim Biophys Acta 441: 93–102.PubMedCrossRefGoogle Scholar
  35. Lamb RG, Fallon HJ (1974) Glycerolipid formation from sn-glycerol-3-phosphate by rat liver cell fractions: Role of phosphatidate phosphohydrolase. Biochim Biophys Acta 348: 166–178.PubMedCrossRefGoogle Scholar
  36. Lands WM (1960) Metabolism of glycerolipids. II. The enzymatic acylation of lysolecithin. J Biol Chem 235: 2233–2237.PubMedGoogle Scholar
  37. Lee AG (1976) Model for action of local anaesthetics. Nature (Lond) 262: 545–548.CrossRefGoogle Scholar
  38. Lee AG (1977a) Lipid phase transitions and phase diagrams. I. Biochim Biophys Acta 472: 237–281.CrossRefGoogle Scholar
  39. Lee AG (1977b) Lipid phase transitions and phase diagrams. II. Mixtures involving lipids. Biochim Biophys Acta 472: 285–344.PubMedCrossRefGoogle Scholar
  40. Lee AG (1979) A consumers guide to models of local anesthetic action. Anesthesiology 51: 64–71.PubMedCrossRefGoogle Scholar
  41. Leibowitz-BenGershon Z, Kobiler I, Gatt S (1972) Lysophospholipases of rat brain. J Biol Chem 247: 6840–6847.Google Scholar
  42. Leibowitz Z, Gatt S (1968) Isolation of lysophospholipase, free of phospholipase activity from rat brain. Biochim Biophys Acta 164: 439–441.CrossRefGoogle Scholar
  43. Lüllmann H, Lüllmann-Rauch R, Wassermann O (1975) Drug-induced phospholipidoses. CRC Crit Rev Toxicol 4: 185–218.PubMedGoogle Scholar
  44. Lüllmann H, Lüllman-Rauch R, Wassermann O (1978) Lipidosis induced by amphiphilic cationic drugs. Biochem Pharmacol 27: 1103–1108.PubMedCrossRefGoogle Scholar
  45. Lüllmann H, Weling M (1979) The binding of drugs to different polar lipids in vitro. Biochem Pharmacol 28: 3409–3415.PubMedCrossRefGoogle Scholar
  46. Lüllmann-Rauch R (1979) Drug-induced lysosomal storage diseases. In: Dingle JT, Jacques PJ (eds): Lysosomes in Biology and Pathology. Vol. 6, North-Holland, Amsterdam, pp. 49–130.Google Scholar
  47. Martin-Sanz P, Hopewell R, Brindley DN (1985) Spermine promotes the translocation of phosphatidate phosphohydrolase from the cytosol to the microsomal fraction of rat liver and it enhances the effects of oleate in this respect. FEBS Lett 179: 262–266.PubMedCrossRefGoogle Scholar
  48. Martonosi A, Donley J, Halpin RA (1968) Sarcoplasmic reticulum. III. The role of phospholipids in the adenosine triphosphatase activity and Ca++-transport. J Biol Chem 243: 61–70.PubMedGoogle Scholar
  49. Mitchell MP, Brindley DN, Hübscher G (1971) Properties of phosphatidate phosphohydrolase. Eur J Biochem 18: 214–220.PubMedCrossRefGoogle Scholar
  50. Pakalapati G, Debuch H (1982) Studies on the liberation of fatty acids from 2-lysophosphatidylcholine by a liver lysosomal enzyme activity from chloroquine-treated rats. Hoppe-Seyler’s Z Physiol Chem 363: 573–580.PubMedCrossRefGoogle Scholar
  51. Pang KY, Miller KW (1978) Cholesterol modulates the effects of membrane perturbers in phospholipid vesicles and biomembranes. Biochim Biophys Acta 511: 1–9.PubMedCrossRefGoogle Scholar
  52. Pappu AS, Hauser G (1981a) Alterations of phospholipid metabolism in rat cerebral cortex mince induced by cationic amphiphilic drugs. J Neurochem 37: 1006–1014.PubMedCrossRefGoogle Scholar
  53. Pappu AS, Hauser G (1981b) Changes in brain polyphosphoinositide metabolism induced by cationic amphiphilic drugs in vitro. Biochem Pharmacol 30: 3243–3246.PubMedCrossRefGoogle Scholar
  54. Pappu AS, Hauser G (1982) Phospholipid metabolism changes in rat tissues in vitro after injections of propranolol. J Pharmacol Exptl Ther 222: 109–115.Google Scholar
  55. Pappu AS, Hauser G (1983) Propranolol-induced inhibition of rat brain cytoplasmic phosphatidate phosphohydrolase. Neurochem Res 8: 1565–1575.PubMedCrossRefGoogle Scholar
  56. Pappu A, Hostetler KY (1984) Effect of cationic amphiphilic drugs on the hydrolysis of acidic and neutral phospholipids by liver lysosomal phospholipase A. Biochem Pharm 33: 1639–1644.PubMedCrossRefGoogle Scholar
  57. Pelech SL, Cook HW, Paddon HB, Vance DE (1984a) Membrane-bound CTP: phosphocholine cytidylyltransferase regulates the rate of phosphatidylcholine synthesis in HeLa cells treated with unsaturated fatty acids. Biochim Biophys Acta 795: 433–440.PubMedCrossRefGoogle Scholar
  58. Pelech SL, Paddon HB, Vance DE (1984b) Phorbol esters stimulate phosphatidylcholine biosynthesis by translocation of CTP: phosphocholine cytidylyltransferase from cytosol to microsomes. Biochim Biophys Acta 795: 447–451.PubMedCrossRefGoogle Scholar
  59. Pelech SL, Pritchard PH, Brindley DN, Vance DE (1983) Fatty acids promote translocation of CTP: phosphocholine cytidylyltransferase to the endoplasmic reticulum and stimulate rat hepatic phosphatidylcholine synthesis. J Biol Chem 258: 6782–6788.PubMedGoogle Scholar
  60. Pelech SL, Vance DE (1984) Trifluoperazine and chlorpromazine inhibit phosphatidylcholine biosynthesis and CTP: phosphocholine cytidylyltransferase in HeLa cells. Biochim Biophys Acta 795: 441–446.PubMedCrossRefGoogle Scholar
  61. Reddy PV, Natarajan V, Schmid PC, Schmid HHO (1983) N-Acylation of dog heart ethanolamine phospholipids by transacylase activity. Biochim Biophys Acta 750: 472–480.PubMedCrossRefGoogle Scholar
  62. Rooney EK, Lee AG (1983) Binding of hydrophobic drugs to lipid bilayers and to the (Ca2+ +Mg2+)-ATPase. Biochim Biophys Acta 732: 428–440.PubMedCrossRefGoogle Scholar
  63. Seeman P, Roth S (1972) General anesthetics expand cell membranes at surgical concentrations. Biochim Biophys Acta 255: 171–177.PubMedCrossRefGoogle Scholar
  64. Seydel JK, Wassermann O (1976) NMR studies on the molecular basis of drug-induced phospholipidosis. II. Interaction between several amphiphilic drugs and phospholipids. Biochem Pharmacol 25: 2357–2364.PubMedCrossRefGoogle Scholar
  65. Shapiro B (1953) Purification and properties of a lysolecithinase from pancreas. Biochem J 53: 663–666.PubMedGoogle Scholar
  66. Singer MA (1977) Interaction of dibucaine and propranolol with phospholipid bilayer membranes — effect of alterations in fatty acyl composition. Biochem Pharmacol 26: 51–57.PubMedCrossRefGoogle Scholar
  67. Smith ME, Sedgwick B, Brindley DN, Hübscher G (1967) The role of phosphatidate phosphohydrolase in glyceride biosynthesis. Eur J Biochem 3: 10–11.CrossRefGoogle Scholar
  68. Sturton RG, Brindley DN (1977) Factors controlling the activities of phosphatidate phosphohydrolase and phosphatidate cytidylyltransferase. Biochem J 162: 25–32.PubMedGoogle Scholar
  69. Surewicz WK (1982) Quinidine is a strong perturber of acidic phospholipid bilayer order and fluidity. Biochim Biophys Acta 692: 315–318.PubMedCrossRefGoogle Scholar
  70. Tanaka R, Strickland KP (1965) Role of phospholipid in the activation of Na+, Reactivated adenosine triphosphatase of beef brain. Arch Biochem Biophys 111: 583–592.PubMedCrossRefGoogle Scholar
  71. The R, Hasselbach W (1972) Properties of the sarcoplasmic ATPase reconstituted by oleate and lysolecithin after lipid depletion. Eur J Biochem 28: 357–363.PubMedCrossRefGoogle Scholar
  72. van den Bosch H, Aarsman AJ, De Jong JGN, van Deenen LLM (1973) Studies on lysophospholipases. I. Purificaton and some properties of a lysophospholipase from beef pancreas. Biochim Biophys Acta 296: 94–104.PubMedCrossRefGoogle Scholar
  73. van den Bosch H, Aarsman AJ, Slotboom AJ, van Deenen LLM (1968) On the specificity of rat liver lysophospholipase. Biochim Biophys Acta 164: 215–225.PubMedCrossRefGoogle Scholar
  74. van Heusden GPH, Reutelingsperger CPM, van den Bosch H (1981) Substrate specificity of lysophospholipase-transacylase from rat lung and its action on various physical forms of lysophosphatidylcholine. Biochim Biophys Acta 663: 22–33.PubMedCrossRefGoogle Scholar
  75. Vianen GM, van den Bosch H (1978) Lysophospholipase and lysophosphatidylcholine: lysophosphatidylcholine transacylase from rat lung: Evidence for a single enzyme and some aspects of its specificity. Arch Biochem Biophys 190: 373–384.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • George Hauser
    • 1
  • Omanand Koul
    • 1
  • Ubaldo Leli
    • 1
  1. 1.Ralph Lowell Laboratories, McLean HospitalHarvard Medical SchoolBelmontUSA

Personalised recommendations